Triall is building the world’s first blockchain-enabled clinical research ecosystem, serving and connecting all who are involved in carrying out clinical trials. Triall aims to promotes trust, research data integrity, auditability, and system interoperability, applying the strengths of blockchain technology where these truly add value.
Our aim is to tackle many of the persisting issues that make medical innovation an overly complex, lengthy, and resource-inefficient endeavor.
The Triall ecosystem comprises projects across the entire clinical research domain. These projects share a common vision of making clinical trials smarter, safer and more-efficient by promoting research data integrity, auditability, system integration and operational efficiency. Triall positions itself as a translational agent, bridging blockchain and data management expertise with a profound understanding of clinical research and the needs and preferences of clinical research professionals. On one end, Triall is engaged in developing its own proprietary blockchain-enabled Software as a Service solutions such as Verial eTMF and Triall CTMS. On the other end, Triall engages in developing blockchain-enabled Platform as a Service components (APIs) for a number of public-private initiatives.
Experienced CEO in the pharmaceutical and clinical research domain, with extensive experience in managing international clinical trials (phase I-IV). Fully geared towards making innovative treatments accessible to those in need.
Experienced blockchain developer and serial entrepreneur with over 15 years of experience in various CTO roles. Guide of the Factom Blockchain, responsible for its full decentralization.
Academic entrepreneur, project manager and consultant. Co-founder of two successful Life Sciences management consultancies. Holds a cum laude PhD in science commercialization.
Corporate lawyer and deal-maker with extensive experience as legal counsel in the pharmaceutical and health care industries. Headed the legal department of Erasmus University Medical Center.
Researcher, management consultant, and marketeer with a background in Biomedical Sciences and Entrepreneurship. Passion for making complex technologies explainable and understandable to a broader audience.
PhD candidate and consultant in medical innovation management with degrees in Biomedical Sciences (Health Technology Assessment) and Entrepreneurship. Passionate (self-taught) graphic designer with experience in commercial web- and UX design projects for over 12 years.
Project manager and clinical research scientist, operating at the interface between industry and academia. Experienced in clinical operations, medical writing and microbiota R&D. Dedicated to translating the benefits of blockchain technology to end-user functionalities in the clinical trial domain.
Technology entrepreneur and blockchain enthusiast. Founded Dizer Capital, a private equity firm focused on supporting early stage businesses in DLT/blockchain, clean energy, and financial inclusion.
Immunologist, Full Professor and sequential entrepreneur. Co-founded over 20 companies in the Life Sciences. Government and boardroom advisor on biomedical innovation and entrepreneurship.
Head of Integrated Clinical and Operational Analytics in Enabling Business and Information Solutions at Janssen, with extensive experience in designing and implementing data-driven systems for clinical trial monitoring.
Full Professor of Primary Care Medicine and Strategic Chair of eHealth Applications in Disease Management at LUMC. Founder and Director of the National eHealth Living Lab (NeLL). Authored 190+ peer-reviewed papers on eHealth, mHealth, and disease management.
Managing partner of FutureLab. Co-developed the first specification for universal identity on the Internet, invented the concept of eMarkets, and helped to establish the foundational guidelines for the semantic Web.
Advisor at UC Berkeley, adjunct professor in management at HKUST and partner at FutureLab. Highly successful international VC and entrepreneur with more than 30 years of experience in innovation and entrepreneurship.
Professor (Health care consumers & Experienced health) at Nyenrode Business University. International expert in health consumer behavior, methodology and health care innovation. Working for Janssen (part of Johnson & Johnson) from 2000 onward as innovation manager.
Head of Quality Assurance at Galera Therapeutics, with extensive knowledge of SOP management, GxP inspection readiness, computer system validation, and quality compliance.
All-round clinical operations and quality management specialist, with 25+ years in pharmaceutical R&D and clinical trial quality management. Compliance expert in FDA, EMA, and ICH-GCP laws and regulations.
Head clinical operations, with 10+ years in managing international clinical trials (phase I-IV) across therapeutic areas. Currently leading CEPI and Horizon2020 clinical trials.
Software and IT entrepreneur, with 20+ years in document management solutions. Founder of Magellan Benelux (sold to OpenText) and co-founder of Sphereon, optimizing document processing with enterprise-grade microservices architectures, blockchain and AI. Invited speaker on blockchain-enabled document management solutions across the globe.
Founder of TrialDocs, with over two decades of experience in the pharma, CRO and eClinical industries. Expert in simplifying workflows and procedures at site-level to improve cooperation between clinical research sites and industry stakeholders.
Director business development and recruitment, with 15+ years in clinical research within the pharmaceutical and contract research services industry. In 2010 he changed his career path to providing staffing solutions for Life Sciences companies and CROs.
We’re proud to present you the Triall whitepaper. It covers over 40 pages of detailed information on our vision and plans for a blockchain-enabled clinical trial ecosystem, including: